Kenneth d’Entremont
Vermogen: 5 M $ op 30-06-2026
Vermogen: 5 M $ op 30-06-2026
Mr. Kenneth d’Entremont is a Chief Executive Officer & Director at Medexus Pharmaceuticals, Inc. He is on the Board of Directors at Medexus Pharmaceuticals, Inc. Mr. d’Entremont was previously employed as a President, Chief Executive Officer & Director by Medexus, Inc. and a General Manager & VP-Business Development by Sanofi Canada, Inc. He received his undergraduate degree from McMaster University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 01-12-2025 | 1.504.807 ( 4,75% ) | 5 M $ | 30-06-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| MEDEXUS PHARMACEUTICALS INC. | Algemeen Directeur | 17-12-2018 |
| Bedrijven | Functie | Einde |
|---|---|---|
Medexus, Inc.
Medexus, Inc. Drugstore ChainsRetail Trade Engages in licensing, registration, marketing, sales and distribution of pharmaceutical products | Oprichter | 17-12-2018 |
Sanofi Canada, Inc.
Sanofi Canada, Inc. Pharmaceuticals: MajorHealth Technology Researches, develops, manufactures and distributes pharmaceutical products | Corporate Officer/Principal | 01-01-1999 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
McMaster University
McMaster University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medexus Pharmaceuticals, Inc.
Medexus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides healthcare products which focuses on therapeutic areas of auto-immune disease and pediatrics | Health Technology |
Sanofi Canada, Inc.
Sanofi Canada, Inc. Pharmaceuticals: MajorHealth Technology Researches, develops, manufactures and distributes pharmaceutical products | Health Technology |
Medexus, Inc.
Medexus, Inc. Drugstore ChainsRetail Trade Engages in licensing, registration, marketing, sales and distribution of pharmaceutical products | Retail Trade |
Kies jouw editie
Alle financiële informatie op nationaal niveau